BioSpace News Archive

Tenax Therapeutics, Inc. announced that it received notice from The Nasdaq Stock Market, LLC on June 2, 2020 indicating that the Company has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550 for continued listing on The Nasdaq Capital Market.

Calyxt, Inc. announced that its high oleic low linolenic soybean has been deemed a non-regulated article under the “Am I Regulated?” process by Biotechnology Regulatory Services of the Animal and Plant Health Inspection Service, an agency of the United States Department of Agriculture.

Evotec licenses novel polycystic ovary syndrome target identified by Celmatix through its Reproductive Atlas™ platform to Bayer

Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease Designation (RPDD) to 67 Cu-SARTATE™, a therapy for the clinical management of neuroblastoma. The FDA defines a “rare pediatric diseas

Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), developer of novel wound care and biosurgical devices, will be featured as a presenting company at the Virtual Summer Summit. The conference is being held on June 9-12, 2020. Chief Executive Officer, Terrence W. Norchi, MD, is scheduled to provide a corporate update on Wednesday, June 10th at 1:35 PM ET. Dr. Norchi will be available for 1x1 virtual meetings with investors who

Aligos Therapeutics, Inc. (Aligos), a private biotechnology company focused on the development of targeted, antiviral therapies including chronic hepatitis B (CHB) and COVID-19 as well as therapeutics for NASH, today announced the appointment of Lesley Ann Calhoun as chief financial officer. Ms. Calhoun will serve as a member of the Aligos leadership team and will report to Aligos’ chief executive officer, Lawrence Blatt, Ph.D., MB

Business Activity Index at 41%; New Orders Index at 41.9%; Employment Index at 31.8%; Supplier Deliveries Index at 67%

Prilenia Therapeutics B.V., a clinical stage biotech company focused on developing novel treatments for neurodegenerative and neurodevelopmental disorders, announces that is has raised $62.5M in a Series A financing round to launch the Company’s planned HD and ALS late-stage clinical trials. The funding round was led by Forbion and included new investors, Morningside Venture Investments

MOBILion Systems, Inc. is showcasing its first ion mobility separations product to the biopharma drug development and academic research markets, with data from its first beta users, during the American Society for Mass Spectrometry’s (ASMS) virtual conference.

Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that it will participate in the Goldman Sachs 41st Annual Global Healthcare Conference, held virtually on Tuesday, June 9, 2020. Geoff Martha, Medtronic chief executive officer, will answer questions about the company beginning at 8:00 a.m. EDT (7:00 a.m. CDT). A live audio webcast of the session will be available on June 9, 2020, by clicking on the Investor Event